Trump’s Drug-Pricing Push to Cut Access Outside US, Study Finds

Cheaper pills at home, pricier everywhere else — someone always pays the list price.

The Trump administration’s push to bring US drug spending down is a powerful incentive for pharmaceutical companies to boost prices and reduce access elsewhere in the world, a study found.